Induction of β3-Adrenergic Receptor Functional Expression following Chronic Stimulation with Noradrenaline in Neonatal Rat Cardiomyocytes
Open Access
- 1 January 2006
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 316 (1) , 392-402
Abstract
This study aimed to characterize β3-adrenergic receptors (ARs) in rat neonatal cardiomyocytes using the noradrenaline (NOR) properties to modulate the expression and function of the three β-ARs. We assessed the effect of NOR (physiological nonselective agonist), isoprenaline (ISO, β-nonselective agonist), dobutamine (DOB, β1-selective agonist), and procaterol (PROC, β2-selective agonist) on cAMP accumulation using cardiomyocytes untreated or treated with 100 μM NOR for 24 h. The inhibition of forskolin-stimulated cAMP accumulation was determined using NOR, isoprenaline, and the β3-selective agonists 4-[2-[(2-(3-chlorophenyl)-2-hydroxyethyl)amino]propyl]phenoxyacetic acid (BRL 37344) and 5-[-2-([-2-(3-chlorophenyl)-2-hydroxyethyl]amino)propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316243). The experiments were performed in the absence or presence of propranolol or 2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP 20712A) and/or 1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol hydrochloride (ICI 118551) to inhibit β1- and β2-AR stimulation and 1-(2-ethylphenoxy)-3-[[1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino-(2S)-2-propanol hydrochloride (SR 59230A) (β3-selective antagonist). In addition, the level of the three subtypes was determined by reverse transcription polymerase chain reaction and Western blotting. NOR pretreatment decreased the activation of cAMP induced by NOR, isoprenaline, and DOB, whereas PROC response was abolished. The inhibition of NOR response by CGP 20712A or ICI 118551 demonstrated that β1- and β2-ARs are down-regulated and that β2-AR functional activity was also abolished in cardiomyocytes exposed to chronic stimulation. β3-AR function was observed with NOR and ISO when β1-/β2-ARs were blocked and with both β3-selective agonists in NOR-treated cells only. This response was completely inhibited by SR 59230A and involved Gi protein. Furthermore, the results from functional studies agree well with those from expression experiments. In conclusion, these data provide strong evidence that β3-ARs are functionally up-regulated and coupled to Gi protein in rat neonatal cardiomyocytes following chronic exposure to NOR when β1- and β2-ARs are down-regulated.Keywords
This publication has 40 references indexed in Scilit:
- Mechanisms of β3‐adrenoceptor‐induced eNOS activation in right atrial and left ventricular human myocardiumBritish Journal of Pharmacology, 2004
- Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytesBritish Journal of Pharmacology, 2004
- β3-Adrenergic regulation of an ion channel in the heart—inhibition of the slow delayed rectifier potassium current IKs in guinea pig ventricular myocytesCardiovascular Research, 2002
- Upregulation of Functional β3-Adrenergic Receptor in the Failing Canine MyocardiumCirculation Research, 2001
- The Effect of Diabetes on Expression of β1-,β2-, and β3-Adrenoreceptors in Rat HeartsDiabetes, 2001
- The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.Journal of Clinical Investigation, 1998
- Involvement of G-protein βγ subunits in coupling the adenosine A1 receptor to phospholipase C in transfected CHO cellsEuropean Journal of Pharmacology, 1998
- Role of β1- and β3-adrenoceptors in the regulation of lipolysis and thermogenesis in rat brown adipocytesAmerican Journal of Physiology-Cell Physiology, 1997
- Differential interaction of β1- and β3-adrenergic receptors with Gi in rat adipocytesCellular Signalling, 1994
- The rat β3‐adrenergic receptor gene contains an intronFEBS Letters, 1993